Support renal research within the Kolling Institute

Chronic kidney disease (CKD) is not only a significant health issue in Australia, but also a global concern, affecting millions of people worldwide and placing immense pressure on healthcare systems across the globe. In Australia, the growing prevalence of CKD is driven by factors like diabetes and hypertension, and the impact on individuals and the healthcare system is becoming more pronounced. Research into CKD is crucial for improving early detection, understanding risk factors, and developing more effective treatments. The Kolling Institute has made CKD a Priority Research Area (PRA), reflecting its commitment to advancing both local and global solutions for this urgent health challenge.

With CKD often progressing silently until it reaches advanced stages, research is key to preventing kidney failure, which requires expensive treatments like dialysis or transplants. As CKD rates continue to rise globally, funding research is critical not only for improving patient outcomes in Australia, but also for addressing the worldwide burden of the disease. By donating to CKD research at the Kolling Institute, you are supporting pioneering work that has the potential to improve lives both nationally and globally. Your contribution will help accelerate research efforts, enhance treatment options, and ultimately reduce the impact of CKD for people around the world.